Cargando…

Interferon gamma in cancer immunotherapy

Immune system can recognize self vs transformed self. That is why cancer immunotherapy achieves notable benefits in a wide variety of cancers. Recently, several papers reported that immune checkpoint blockade therapy led to upregulation of IFNγ and in turn clearance of tumor cells. In this review, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Ling, Lu, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143921/
https://www.ncbi.nlm.nih.gov/pubmed/30039553
http://dx.doi.org/10.1002/cam4.1700
_version_ 1783356064694009856
author Ni, Ling
Lu, Jian
author_facet Ni, Ling
Lu, Jian
author_sort Ni, Ling
collection PubMed
description Immune system can recognize self vs transformed self. That is why cancer immunotherapy achieves notable benefits in a wide variety of cancers. Recently, several papers reported that immune checkpoint blockade therapy led to upregulation of IFNγ and in turn clearance of tumor cells. In this review, we conducted an extensive literature search of recent 5‐year studies about the roles of IFNγ signaling in both tumor immune surveillance and immune evasion. In addition to well‐known functions, IFNγ signaling also induces tumor ischemia and homeostasis program, resulting in tumor clearance and tumor escape, respectively. The yin and the yang of IFNγ signaling are summarized. Thus, this review helps us to comprehensively understand the roles of IFNγ in tumor immunity, which contributes to better design and management of clinical immunotherapy approaches.
format Online
Article
Text
id pubmed-6143921
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-61439212018-09-24 Interferon gamma in cancer immunotherapy Ni, Ling Lu, Jian Cancer Med Cancer Biology Immune system can recognize self vs transformed self. That is why cancer immunotherapy achieves notable benefits in a wide variety of cancers. Recently, several papers reported that immune checkpoint blockade therapy led to upregulation of IFNγ and in turn clearance of tumor cells. In this review, we conducted an extensive literature search of recent 5‐year studies about the roles of IFNγ signaling in both tumor immune surveillance and immune evasion. In addition to well‐known functions, IFNγ signaling also induces tumor ischemia and homeostasis program, resulting in tumor clearance and tumor escape, respectively. The yin and the yang of IFNγ signaling are summarized. Thus, this review helps us to comprehensively understand the roles of IFNγ in tumor immunity, which contributes to better design and management of clinical immunotherapy approaches. John Wiley and Sons Inc. 2018-07-23 /pmc/articles/PMC6143921/ /pubmed/30039553 http://dx.doi.org/10.1002/cam4.1700 Text en © 2018 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Biology
Ni, Ling
Lu, Jian
Interferon gamma in cancer immunotherapy
title Interferon gamma in cancer immunotherapy
title_full Interferon gamma in cancer immunotherapy
title_fullStr Interferon gamma in cancer immunotherapy
title_full_unstemmed Interferon gamma in cancer immunotherapy
title_short Interferon gamma in cancer immunotherapy
title_sort interferon gamma in cancer immunotherapy
topic Cancer Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6143921/
https://www.ncbi.nlm.nih.gov/pubmed/30039553
http://dx.doi.org/10.1002/cam4.1700
work_keys_str_mv AT niling interferongammaincancerimmunotherapy
AT lujian interferongammaincancerimmunotherapy